CoolSculpting® is the leading, non-invasive, body contouring treatment option to reduce fat.1‡ To date, over eight million CoolSculpting® treatment cycles have been completed worldwide.2#
CoolSculpting® uses cryolipolysis, a non-surgical procedure to reduce subcutaneous or ‘pinchable’ fat cells.3 CoolSculpting® works by cooling targeted fat cells to induce the death of these cells without affecting surrounding tissue.4*
‡ Based on HCP tracking market research in the US, UK, Germany, Canada, Brazil, China and Australia (N=526), and global market research of the overall body shaping and skin tightening market
# As of July 2019
* Data obtained from cryolipolysis investigations using a pig model
1. Allergan. Unpublished data. INT-CSC-1950062. CoolSculpting® market research. July 2019
2. Allergan. Unpublished data. INT-CSC-2050157. Number of CoolSculpting® treatment cycles to date. March 2020
3. Kilmer SL, et al. Lasers Surg Med 2017;49(1):63–68.
4. Zelickson B, et al. Dermatol Surg 2009;35(10):1462–70
